2 high quality blue chip ASX 200 shares named as buys by analysts

Analysts have given the thumbs up to these blue chip stars of the ASX 200.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're looking for ASX 200 blue chip shares to add to your portfolio, then read on!

Listed below are two blue chip shares that have been rated as buys by analysts. Here's what they are saying about them right now:

Three excited business people cheer around a laptop in the office

Image source: Getty Images

QBE Insurance Group Ltd (ASX: QBE)

This insurance giant could be a top option for investors looking for ASX 200 blue chip shares to buy.

Especially given its increasingly positive outlook thanks to premium increases, cost outs, and rising interest rates.

It is for these reasons that Morgans is bullish on the company. The broker also highlights that its shares are currently trading at a level that appears "relatively inexpensive."

Morgans has an add rating and $16.96 price target on QBE's shares. This compares favourably to the latest QBE share price of $14.53. In addition, the broker is forecasting dividend yields of 5.6% and 6.4%, respectively, for the next two financial years.

Wesfarmers Ltd (ASX: WES)

Another ASX 200 blue chip share that could be in the buy zone right now is Wesfarmers.

It is the conglomerate behind a high quality portfolio of businesses across a range of industries. This includes Bunnings, Kmart, Target, WesCEF, Officeworks, Priceline, and Flybuys.

UBS is a fan of the company and believes its WesCEF business is well-placed to deliver strong earnings again this year.

The broker currently has a buy rating and $55.50 price target on its shares. So, with the Wesfarmers share price trading at $49.76, this suggests potential upside of 11.5% for investors.

In addition, income investors can expect some attractive dividend yields in the near term. UBS is forecasting 3.7% and 4% dividend yields, respectively, over the next two years.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Blue Chip Shares

A man looking at his laptop and thinking.
Blue Chip Shares

These ASX blue chips now look too cheap to ignore

These blue chips could be worth a closer look after sharp declines.

Read more »

Young woman thinking with laptop open.
Blue Chip Shares

Why is everyone selling Wesfarmers shares?

It looks like the retail conglomerate fell out of favour with investors this year.

Read more »

Four business people wearing formal business suits and ties walk abreast on a wide paved surface with their long shadows falling on the ground ahead of them.
Blue Chip Shares

How did these ASX blue-chip shares perform in March?

Did these blue-chips beat the market in March?

Read more »

Couple looking at their phone surprised, symbolising a bargain buy.
Blue Chip Shares

Are these ASX blue chips now too cheap to ignore?

Let's see why these shares could be seriously undervalued at current levels.

Read more »

A woman gives two fist pumps with a big smile as she learns of her windfall, sitting at her desk.
Blue Chip Shares

3 reasons to buy Wesfarmers shares today

The retail conglomerate is a no-brainer buy in my book.

Read more »

ASX shares buy Street signs stating 'Winners' and 'Losers' in front of urban backdrop
Blue Chip Shares

How are these 5 ASX share giants really tracking in 2026?

Some are struggling, while others are thriving, proving that opportunity is never far away.

Read more »

Happy work colleagues give each other a fist pump.
Blue Chip Shares

My best blue-chip ASX 200 buys for April

Looking for quality in uncertain markets? These three ASX 200 shares stand out to me.

Read more »

A woman scratches her head, thinking is this a no-brainer?
Healthcare Shares

Does this ASX 200 stock's fall make it a no-brainer buy?

Despite a major transformation, this stock is down more than 20%. Is this an opportunity?

Read more »